Comparison of Narrowband UV-B With Psoralen–UV-A Phototherapy for Patients With Early-Stage Mycosis Fungoides

Key Points

Question How does the efficacy of narrowband UV-B compare with that of psoralen–UV-A for early-stage mycosis fungoides?

Findings In this systematic review and meta-analysis of 7 studies with 778 patients with early-stage mycosis fungoides, response rates to narrowband UV-B were similar to those for psoralen–UV-A. No significant difference was found between narrowband UV-B and psoralen–UV-A in terms of adverse effects.

Meaning The findings suggest that narrowband UV-B is a viable and safe alternative to psoralen–UV-A for treatment of early-stage mycosis fungoides.

Abstract

Importance Phototherapy is one of the mainstays of treatment for early mycosis fungoides (MF). The most common modalities are psoralen–UV-A (PUVA) and narrowband UV-B (NBUVB).

Objective To compare the efficacy and adverse effects of PUVA vs NBUVB in early-stage MF.

Data Sources A systematic review was performed by searching Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled Trials, Ovid Medline, PubMed, Cochrane Library, American College of Physicians ACP Journal Club, and Database of Abstracts of Review of Effectiveness from inception to March 30, 2018. UV A, PUVA, mycosis fungoides, Sézary syndrome, cutaneous T-cell lymphoma, UV B, and UVB were used as either key words or MeSH terms.

Study Selection Studies of cohorts with histologically confirmed early-stage MF, defined as stages IA, IB, and IIA, that compared PUVA vs NBUVB, had at least 10 patients in each comparator group, and reported outcomes of response to therapy. Exclusion criteria were studies with patients with stage IIB or higher MF, pediatric patients, fewer than 10 in each comparator group, noncomparative studies, case reports, and abstract studies.

Data Extraction and Synthesis The Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) reporting guideline was followed. Data were pooled using a random-effects model with odds ratio (OR) as effect size.

Main Outcomes and Measures Main outcomes were complete response rate, partial response rate, disease recurrence, and adverse effects, including erythema, nausea, pruritus, phototoxic effects, dyspepsia, and pain.

Results Seven studies were included with a total of 778 patients (405 of 724 [55.9%] men; mean age, 52 years); 527 were treated with PUVA and 251 with NBUVB. Most of the included studies were of poor to moderate quality. Any response was found in 479 of the 527 (90.9%) patients treated with PUVA vs 220 of 251 (87.6%) treated with NBUVB (OR, 1.40; 95% CI, 0.84-2.34; P = .20). Complete response was found in 389 of 527 (73.8%) patients who received PUVA vs 156 of 251 (62.2%) who received NBUVB, which was statistically significant (OR, 1.68; 95% CI, 1.02-2.76; P = .04). Partial response was similar (90 of 501 [18.0%] vs 64 of 233 [27.5%]; OR, 0.58; 95% CI, 0.33-1.04; P = .07). No significant difference was found between PUVA and NBUVB in terms of adverse effects of erythema (38 of 527 [7.2%] vs 17 of 251 [6.7%]; P = .54), nausea (10 of 527 [1.9%] vs 3 of 251 [1.2%]; P = .72), pruritus (2 of 527 [0.4%] vs 4 of 251 [1.7%]; P = .26), phototoxic effects (7 of 527 [1.4%] vs 2 of 251 [0.9%]; P = .72), dyspepsia (6 of 527 [1.2%] vs 0 of 251 [0%]; P = .59), or pain (0 of 527 [0%] vs 2 of 251 [0.9%]; P = .50).

Conclusions and Relevance The findings suggest that PUVA is a potential alternative to NBUVB in the management of early-stage MF. These findings have implications for clinicians involved in the management of early-stage MF.

Full Tex

Vaccines for Children - A Guide for Parents and Caregivers

Vaccines for Children - A Guide for Parents and Caregivers Vaccines have contributed to a significant reduction in many childhood infectious diseases, such as diphtheria, measles, and Haemophilus influenzae type b (Hib). Some infectious diseases, such as polio and smallpox, have been eliminated in the United States due to effective vaccines. It is now rare for children in the United States to experience the devastating and often deadly effects of these diseases that were once common in the United States and other countries with high vaccination coverage. The vast majority of vaccines are given to healthy babies, children and adults; therefore, it is critical that vaccines be demonstrated to be safe and effective. Ensuring the safety and effectiveness of vaccines is one of the Food and Drug Administration's (FDA) top priorities. The Center for Biologics Evaluation and Research (CBER) is the center within FDA that has regulatory oversight of vaccines in the United States assur

Chalazio: bolita en el ojo

Es un pequeño forúnculo que se forma debido al bloqueo e inflamación de una glándula sebácea de Meibomio (orzuelo interno) del parpado. Inicialmente, el chalazión se manifiesta en el enrojecimiento, hinchazón y sensibilidad del parpado. Sin embargo, en unos días el estado cambia, no duele, pero empieza a crecer un quiste en el parpado. El chalazión empieza siendo bastante pequeño, casi imperceptible, pero puede llegar a crecer al tamaño de una arveja (chicharo). Muchas veces este se confunde con el orzuelo que es una inflamación de las glándulas sebáceas de Zeiss (orzuelo externo) y es doloroso. El chalazión por lo general no esta acompañado de una infección, pero puede surgir como consecuencia del orzuelo. Síntomas • Aparición de un forúnculo en la parte superior del parpado • Ojos llorosos • Visión borrosa Para poder diferenciar al Chalazión que requiere una cirugía del orzuelo que en general no requiere cirugía, se debe consultar con el doctor para obtener el tratamient

Enfermedades Venereas o Infecciones de Transmision Sexual

Las enfermedades venéreas o infecciones de transmisión sexual (I.T.S.) son muy comunes y en estos momentos están prácticamente afectando a 20 millones de personas en los Estados Unidos, de los cuales el 20% son latinos, y estos son solo los casos reportados. La incidencia en la comunidad latina está incrementando alarmantemente en jóvenes menores de 25 años donde conforman más del 50% de los casos, mientras que en jóvenes menores de 20 años se da en un 30-40%. El gran problema en nuestra comunidad es la falta de información y comunicación sobre este tema que se considera aun tabú o algo de lo que da vergüenza hablar con los hijos. Estas infecciones se trasmiten no solo a través del contacto sexual oral, vaginal o anal, sino también pueden ser transmitidas a través de la sangre (transfusiones, jeringas infectadas, maquinas de tatuajes, piercings, etc.), sino también pueden ser transmitidas al dar a luz o al darle de lactar a un bebe. Lo importante e

Hola Doctor Daniel

Buscar este blog

Nutrition - Health.com